Cardiovascular Therapy and Prevention, 2015, 14(4)

Editorial

IMPORTANCE OF THE EPIDEMIOLOGIC STUDIES AND EVIDENCE-BASED MEDICINE FOR CLINICAL PRACTICE

Oganov R. G.

FSBI “State Scientific-Prevention Center of the Prevention Medicine” of the Healthcare Ministry. Moscow, Russia

Cardiovascular Therapy and Prevention, 2015; 14(4): 4–7

http://dx.doi.org/10.15829/1728-8800-2015-4-4-7

Original articles

Arterial hypertension

COMBINATION THERAPY WITH BISOPROLOL AND AMLODIPINE IN TREATMENT OF ARTERIAL HYPERTENSION PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Nikitin V. A.1, Gosteva E. V.1,2, Pyshnograeva L. V.2, Vasilyeva L. V.1

1 SBEI HPE Voronezh State Medical Academy of the Healthcare Ministry. Voronezh, Russia; 2City Clinical Hospital №20. Voronezh, Russia

Abstract

THE USE OF GENERIC MOXONIDINE IN SYSTEMIC BLOOD PRESSURE ELEVATION

Ruksin V. V.1, Grishin O. V.2, Yashchenkova S. V.3, Onuchin М. В.3

1 North-Western State Medical University n. a. I. M. Mechnikov. Saint-Petersburg, Russia; 2Polyclinics №17. Saint-Petersburg, Russia; 3 Polyclinics №8. Saint-Petersburg, Russia

Abstract

Ischemic heart disease

AFFECT DISORDERS AND LIFE QUALITY IN CORONARY HEART DISEASE PATIENTS UNDER DIFFERENT TREATMENT APPROACHES

Mukhtarenko S. Yu., Murataliev Т. М., Neklyudova Yu. N., Zventsova V. K., Okunova А. А.

National Center of Cardiology and Therapy n. a. M. Mirrakhimov. Bishkek, Kyrgyz Republic

Abstract

MODELING OF THE 10-YEAR SURVIVAL OF MEN 60 YEARS AND OLDER, WITH ISCHEMIC HEART DISEASE

Tancyreva I. V., Volkova E. G, Levashov S. Yu, Shamurova Yu. Yu.

SBEI HPE “South-Ural State Medical University” of the Healthcare Ministry of Russian Federation. Chelyabinsk, Russia

Abstract

PREDICTION OF THE INFLUENCE OF ORIGINAL AND GENERIC ROSUVASTATIN ON DIRECT MEDICAL COSTS OF SECONDARY PREVENTION IN PATIENTS WITH CHRONIC TYPES OF ISCHEMIC HEART DISEASE

Tarlovskaya E. I.1, Nechaeva G. I.2, Malchikova S. V.3, Semenkin А. А.2

1 SBEI HPE Nizhegorodskaya State Medical Academy of the Healthcare Ministry. Nizhniy Novgorod, Russia; 2SBEI HPE Omsk State Medical University of the Healthcare Ministry. Omsk, Russia; 3SBEI HPE Kirovskaya State Medical Academy of the Healthcare Ministry. Kirov, Russia

Abstract

Obesity

PREVENTIVE ACTION OF ORLISTAT ON CARDIOVASCULAR RISKS IN YOUNG OBESITY PATIENTS

Korneeva E. V.

BI HE “Surgut State University of KMAD-Yugra” based at BI KMAD-Yugra “Surgut City Clinical Polyclinics №1”. Surgut, Russia

Abstract

Comorbidity

COMORBIDITIES OF ISCHEMIC HEART DISEASE WITH OTHER NON-COMMUNICABLE DISEASES IN ADULT POPULATION: AGE AND RISK FACTORS ASSOCIATION

Shalnova S. A.1, Oganov R. G.1, Deev A. D.1, Imaeva A. E.1, Lukyanov М. М.1, Artamonova G. V.2, Gatagonova Т. М.3, Grinshtein Yu. I.4, Duplyakov D. V.5, Efanov А . Yu.6, Zhernakova Yu. V.7, Ilyin V. A.8, Libis R. A.9, Minakov A. V.10, Nevzorova V. A. 11, Nedogoda S. V.12, Romanchuk S. A.13, Rotar O. P.14, Trubacheva I. A.15, Shlyakhto E. V.14, Boytsov S. A.1 on behalf of the ESSE-RF study work team#

1 FSBI “State Scientific-Prevention Center of the Prevention Medicine” of the Healthcare Ministry. Moscow, Russia; 2FSBI Scientific-Research Institute of Complex Problems of Cardiovascular Diseases SD RAMS. Kemerovo, Russia; 3SEI HPE “North-Osetin State Medical Academy”. Vladicaucaz, Northern Osetia-Alania, Russia; 4SBEI HPE “Krasnoyarsk State Medical University n. a. Voyno-Yasenetsky” of the Healthcare Ministry. Krasnoyarsk, Russia; 5SBHI “Samara Region Clinical Cardiological Dispensary”. Samara, Russia; 6SBEI HPE “Tyumen State Medical Academy” of the Healthcare Ministry. Tyumen, Russia; 7FSBI “Russian Cardiovascular Scientific-Production Complex” of the Healthcare Ministry. Moscow, Russia; 8FSSI “Institute of Social and Economic Territories Development” RAS. Vologda, Russia; 9SBEI HPE “Orenburg State Medical Academy” of the Healthcare Ministry. Orenburg, Russia; 10SBEI HPE “Voronezh State Medical Academy” of the Healthcare Ministry. Voronezh, Russia; 11SBEI HPE “Pacific-Ocean State Medical University” of the Healthcare Ministry. Vladivostok, Russia; 12SBEI HPE “Volgograd State Medical University” of the Healthcare Ministry. Volgograd, Russia; 13DBHI “Cardiovascular Dispensary”. Ivanovo, Russia; 14FSBI “Almazov North-Western Federal Medical

Research Center” of the Healthcare Ministry. Saint-Petersburg, Russia; 15FSBSI “Scientific-Research Institute of Cardiology”. Tomsk, Russia

Abstract

Chronic heart failure

NEW OPPORTUNITIES IN TREATMENT OF CHRONIC HEART FAILURE WITH NORMAL EJECTION FRACTION

Dushina A. G., Libis R. A.

SBEI HPE Orenburg State Medical University of the Healthcare Ministry. Orenburg, Russia

Abstract

Epidemiology and рrevention

SOCIAL AND ECONOMIC GRADIENTS OF BEHAVIORAL RISK FACTORS IN RUSSIAN POPULATION (BY THE ESSE-RF STUDY)

Kontsevaya A. V.1, Shalnova S. A.1, Balanova Yu. A.1, Deev A. D.1, Artamonova G. V.2, Gatagonova T. M.3, Grinshtein Yu. I.4, Duplyakov D. V.5, Efanov A. Yu.6, Zhernakova Yu. V.7, Ilyin V. A. 8, Konradi A. O.9, Libis R. A.10, Minakov A. V.11, Nevzorova V. A.12, Nedogoda S.V.13 , Oganov R.G.1, Romanchuk S.A.14, Rotar O.P.9, Trubacheva I.A.15, Shlyakhto E.V.9, Boytsov S. A. 1 on behalf of the ESSE-RF study workteam#

1 FSBI “State Scientific-Prevention Center of the Prevention Medicine” of the Healthcare Ministry. Moscow, Russia; 2FSBI Scientific-Research Institute of Complex Problems of Cardiovascular Diseases SD RAMS. Kemerovo, Russia; 3SEI HPE “North-Osetin State Medical Academy”. Vladicaucaz, Northern Osetia-Alania, Russia; 4SBEI HPE “Krasnoyarsk State Medical University n. a. Voyno-Yasenetsky” of the Healthcare Ministry. Krasnoyarsk, Russia; 5SBHI “Samara Region Clinical Cardiological Dispensary”. Samara, Russia; 6SBEI HPE “Tyumen State Medical Academy” of the Healthcare Ministry. Tyumen, Russia; 7FSBI “Russian Cardiovascular Scientific-Production Complex” of the Healthcare Ministry. Moscow, Russia; 8FSSI “Institute of Social and Economic Territories Development” RAS. Vologda, Russia; 9FSBI “Almazov North-Western Federal Medical Research Center” of the Healthcare Ministry. Saint-Petersburg, Russia; 10SBEI HPE “Orenburg State Medical Academy” of the Healthcare Ministry. Orenburg, Russia; 11SBEI HPE “Voronezh State Medical Academy” of the Healthcare Ministry. Voronezh, Russia; 12SBEI HPE “Pacific-Ocean State Medical University” of the Healthcare Ministry. Vladivostok, Russia; 13SBEI HPE “Volgograd State Medical University” of the Healthcare Ministry.

Volgograd, Russia; 14DBHI “Cardiovascular Dispensary”. Ivanovo, Russia; 15FSBSI “Scientific-Research Institute of Cardiology”. Tomsk, Russia

Abstract

EMOTIONAL STATUS AND FOOD PREFERENCE STYLE: THE RESULTS OF THE EPIDEMIOLOGICAL STUDY ESSE-RF IN SAINT-PETERSBURG, SAMARA AND ORENBURG

Rotar O. P.1, Dubinina Е. А .2,3, Orlov A. V.1, Libis R. A.4, Isaeva E. N.4, Basyrova I. R.4, Duplyakov D. V.5,6, Gudkova S. A.6, Solntsev V. N.1, Alyokhin A. N.2, Baranova E. I.1,7, Konradi A. O.1, Shlyakhto E. V.1

1 FSBI “North-Western Federal Medical Research Center” of the Healthcare Ministry. Saint-Petersburg, Russia; 2SBEI HPE Herzen Russian State Pedagogic University, Saint-Petersburg, Russia; 3FSBI Bekhterev Saint-Petersburg Scientific-Research Psychoneurologic Institute of the Healthcare Ministry, Saint-Petersburg, Russia; 4SBEI HPE “Orenburg State Medical Academy” of the Healthcare Ministry. Orenburg, Russia; 5SBEI HPE “Samara State Medical University” of the Healthcare Ministry, Samara, Russia; 6SBHI “Samara Region Clinical Cardiovascular Dispensary”, Samara, Russia; 7SBEI HPE The First Saint-Petersburg State Medical University n. a. Pavlov of the Healthcare Ministry, Saint-Petersburg, Russia

Abstract

Opinion on a problem

The selection problems of antithrombotic therapy in nonvalvular atrial fibrillation with comorbidities

Koziolova N. A., Polyanskaya Е. А.

SBEI HPE “Perm State Medical University n. a. E. A. Wagner” of the Healthcare Ministry. Perm, Russia

Abstract

PHARMACOECONOMIC ASPECTS OF EPLERENONE USAGE IN CHRONIC HEART FAILURE

Lopatin Yu. M.1,2, Lopatina E. Yu.3

1 SBEI HPE Volgograd State Medical University of the Healthcare Ministry. Volgograd, Russia; 2SBHI Volgograd Regional Clinical Cardiological Centre. Volgograd, Russia; 3University of Calgary. Calgary, Canada

Abstract

Reviews

GUT MICROBIOTA AND CARDIOVASCULAR RISK FACTORS. PART 1. GUT MICROBIOTA, AGE AND SEX

Kashtanova D. A., Tkacheva O. N., Boytsov S. A.

FSBI “State Scientific-Prevention Center of the Prevention Medicine” of the Healthcare Ministry. Moscow, Russia

Abstract

The experience of the recent decade has led to ability of complex evaluation of human health, including not only external influences, genetic determinants, but to regard human body as an “environment” for billions of microbes that continuously interact with the host. Microbiota of the gut — the most “inhabitated organ” — is it was discovered, relates to a variety of cardiovascular risk factors. In the series of articles the description of recent data to be provided of the relations of gut microbiota and cardiovascular risk factors. Current article focuses on the recent views on the relation with no modifiable cardiovascular risk factors — sex and age. Some aspects to be described of the microbiota formation since in the womb development and during ageing, the recent results of the studies are described. Also some data on the relation of the sex and gut microbiota is mentioned.

Cardiovascular Therapy and Prevention, 2015; 14(4): 92–95

http://dx.doi.org/10.15829/1728-8800-2015-4-92-95

Key words: gut microbiota, chronic subclinical inflammation, organism ageing, gut microbiota formation.

THEORETICAL ASPECTS (DEFECTS) OF THE PREVENTION DIRECTION IN MEDICINE (CARDIOLOGY) AND THEIR APPLIED SIGNIFICANCE: CRITICS AND SUGGESTIONS

Dimov A. S.

Izhevsk State Medical Academy of the Healthcare Ministry. Izhevsk, Russia

Abstract

Prevention of the diseases, particularly cardial pathology, has its very significant controversies. The idea of the risk factors did not give the expected results. Causality of the majority of diseases is still unknown or not fully understood. This leads to inability of predicting. The article provides the reader with theoretical and practical experience evaluation of the XX century upon the problem of causality (etiology) of diseases. The original definition of causality is expressed and vindicated as its

applied significance.

Cardiovascular Therapy and Prevention, 2015; 14(4): 96–102

http://dx.doi.org/10.15829/1728-8800-2015-4-96-102

Key words: prediction, prevention, etiology, causality, risk factors, conditionalism, dialectics.

CURRENT ISSUES OF OBESITY CLASSIFICATION

Samorodskaya I. V.1, Bolotova E. V.2, Boytsov S. A.1

1 FSBI “State Scientific-Prevention Center of the Prevention Medicine” of the Healthcare Ministry. Moscow, Russia; 2SBEI HPE “Kubanskiy State Medical University” of the Healthcare Ministry. Krasnodar, Russia

Abstract

Яндекс.Метрика